Back
Virbac SA 10K Form
Sell
16
VRBCF
Virbac SA
Last Price:
339.23
Seasonality Move:
10.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VRBCF News And Ratings
See the #1 stock for the next 7 days that we like better than VRBCF
VRBCF Financial Statistics
Sales & Book Value
| Annual Sales: | $1.35B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 35.77 |
| Annual Sales: | $127.26 |
| Price / Book: | 2.67 |
Profitability
| EPS (TTM): | 18.12260 |
|---|---|
| Net Income (TTM): | $151.75M |
| Gross Margin: | $876.48M |
| Return on Equity: | 14.94% |
| Return on Assets: | 8.97% |
Virbac SA Earnings Forecast
Key Virbac SA Financial Ratios
- The Gross Profit Margin over the past 20 years for VRBCF is 64.93%.
- The Selling, General & Administrative Expenses for VRBCF have been equal to 0.00% of Gross Profit Margin.
- The Research & Development expenses have been 1.51% of Revenue.
- The Interest Expense is 7.32% of Operating Income.
- The Net Earning history of VRBCF is 9.73% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 14 years.
Virbac SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | VRBCF |
| Website: | virbac.com |
Debt
| Debt-to-Equity Ratio: | 0.37 |
|---|---|
| Current Ratio: | 1.65 |
| Quick Ratio: | 0.85 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.79 |
|---|---|
| Forward P/E Ratio: | 0 |